↓ Skip to main content

Dove Medical Press

Treatment with Anlotinib After Chemotherapy and EGFR-TKI Resistance in Lung Adenosquamous Carcinoma with Concurrent EGFR and PIK3CA Mutations: A Case Report and Literature Review

Overview of attention for article published in Cancer Management and Research, September 2021
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
9 Mendeley
Title
Treatment with Anlotinib After Chemotherapy and EGFR-TKI Resistance in Lung Adenosquamous Carcinoma with Concurrent EGFR and PIK3CA Mutations: A Case Report and Literature Review
Published in
Cancer Management and Research, September 2021
DOI 10.2147/cmar.s326094
Pubmed ID
Authors

Yonghui Wu, Kai Zhang, Jiexia Guan, Weibin Wu, Jian Zhang, Huiguo Chen

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 9 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 9 100%

Demographic breakdown

Readers by professional status Count As %
Other 1 11%
Student > Doctoral Student 1 11%
Student > Ph. D. Student 1 11%
Student > Master 1 11%
Student > Postgraduate 1 11%
Other 0 0%
Unknown 4 44%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 1 11%
Biochemistry, Genetics and Molecular Biology 1 11%
Computer Science 1 11%
Medicine and Dentistry 1 11%
Unknown 5 56%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 January 2022.
All research outputs
#20,420,242
of 22,971,207 outputs
Outputs from Cancer Management and Research
#1,402
of 2,014 outputs
Outputs of similar age
#354,091
of 427,350 outputs
Outputs of similar age from Cancer Management and Research
#78
of 121 outputs
Altmetric has tracked 22,971,207 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,014 research outputs from this source. They receive a mean Attention Score of 3.0. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 427,350 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 121 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.